ClinicalTrials.Veeva

Menu

Markers of Defective Membrane Remodelling in Scott-like Syndromes

U

University Hospital, Strasbourg, France

Status

Terminated

Conditions

Familial Bleeding Disorder
Scott Syndrome
Unexplained Isolated Provoked Hemorrhages

Treatments

Other: Blood withdrawal

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Purpose: Identification of the gene(s) involved in plasma membrane remodelling. Identification of the circulating markers affected by the defective membrane remodelling in a collection of families with unexplained provoked hemorrhages and evaluation of their prognosis value in the assessment of the hemostatic cellular response.Hypothesis: Scott syndrome is rare a familial disorder characterized by provoked haemorrages in homozygous-type patients due to isolated membrane remodelling deficiency. Membrane remodelling is necessary for cellular hemostatic responses.

Enrollment

29 patients

Sex

All

Ages

2 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with unexplained provoked hemorrhages (surgery, tooth extraction, birth ...), and associated with reduced prothrombin consomption (residual prothrombine in serum > à 5%).
  • Family members of the patients defined above, with or without unexplained hemorrhages (symptomatic or not).
  • Patient's approval based on detailed information given by the pratician

Exclusion criteria

  • Patients with primary hemostasis defect or defective blood coagulation factor(s) possibly explaining the bleeding disorder.
  • Anémia,
  • patients known to be affected by Factor V New York .
  • Patients enrolled in a previous clinical study, the exclusion period of which is not yet completed. - Collaboration to the study rejected by the patient
  • Patients that are not registered for medical care social insurance.

Trial design

29 participants in 2 patient groups

1
Description:
patients with unexplained bleeding disorder
Treatment:
Other: Blood withdrawal
2
Description:
healthy volunteers
Treatment:
Other: Blood withdrawal

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems